Literature DB >> 26427830

Ipilimumab Therapy for Melanoma: A Mimic of Leptomeningeal Metastases.

S Ali1, S-K Lee1.   

Abstract

Entities:  

Year:  2015        PMID： 26427830      PMCID： PMC7964270          DOI： 10.3174/ajnr.A4581

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN： 0195-6108            Impact factor:   3.825


× No keyword cloud information.
  3 in total

1.  Multifocal radiculoneuropathy during ipilimumab treatment of melanoma.

Authors:  Georgios Manousakis; James Koch; R Brian Sommerville; Ahmed El-Dokla; Matthew B Harms; Muhammad T Al-Lozi; Robert E Schmidt; Alan Pestronk
Journal:  Muscle Nerve       Date:  2013-07-27       Impact factor: 3.217

2.  Ipilimumab-induced hypophysitis: MR imaging findings.

Authors:  K J Carpenter; R D Murtagh; H Lilienfeld; J Weber; F R Murtagh
Journal:  AJNR Am J Neuroradiol       Date:  2009-05-27       Impact factor: 3.825

Review 3.  CTLA-4: negative regulator of the immune response and a target for cancer therapy.

Authors:  Ulrich Keilholz
Journal:  J Immunother       Date:  2008-06       Impact factor: 4.456
  3 in total
  6 in total

Review 1.  Proposed diagnostic and treatment paradigm for high-grade neurological complications of immune checkpoint inhibitors.

Authors:  Dustin Anderson; Grayson Beecher; Nabeela Nathoo; Michael Smylie; Jennifer A McCombe; John Walker; Rajive Jassal
Journal:  Neurooncol Pract       Date:  2018-10-04

Review 2.  Neurologic Immune-Related Adverse Events Associated with Immune Checkpoint Inhibition.

Authors:  Peter Chei-Way Pan; Aya Haggiagi
Journal:  Curr Oncol Rep       Date:  2019-11-27       Impact factor: 5.075

Review 3.  Current understanding of interactions between nanoparticles and the immune system.

Authors:  Marina A Dobrovolskaia; Michael Shurin; Anna A Shvedova
Journal:  Toxicol Appl Pharmacol       Date:  2015-12-29       Impact factor: 4.219

4.  Sensitivity of different MRI sequences in the early detection of melanoma brain metastases.

Authors:  Katerina Deike-Hofmann; Daniel Thünemann; Michael O Breckwoldt; Daniel Schwarz; Alexander Radbruch; Alexander Enk; Martin Bendszus; Jessica Hassel; Heinz-Peter Schlemmer; Philipp Bäumer
Journal:  PLoS One       Date:  2018-03-29       Impact factor: 3.240

Review 5.  Leptomeningeal disease: current diagnostic and therapeutic strategies.

Authors:  Gautam Nayar; Tiffany Ejikeme; Pakawat Chongsathidkiet; Aladine A Elsamadicy; Kimberly L Blackwell; Jeffrey M Clarke; Shivanand P Lad; Peter E Fecci
Journal:  Oncotarget       Date:  2017-08-16

6.  Case Report: Pseudomeningeosis and Demyelinating Metastasis-Like Lesions From Checkpoint Inhibitor Therapy in Malignant Melanoma.

Authors:  Teresa Schmidt; Sied Kebir; Elisabeth Livingstone; Andreas Junker; Stefan Zülow; Lazaros Lazaridis; Christoph Oster; Eleftheria Chorti; Daniela Pierscianek; Refik Pul; Kathy Keyvani; Ulrich Sure; Martin Stuschke; Christoph Kleinschnitz; Björn Scheffler; Lisa Zimmer; Martin Glas
Journal:  Front Oncol       Date:  2021-04-15       Impact factor: 6.244
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.